Fungal Culture, Vaginal
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Monitoring therapy, managing chronic recurring disease, or determining the etiology of infectious vaginitis when other tests have been uninformative
Plated to Inhibitory Mold Agar
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Fungal Culture, Vaginal
Specimen Type Describes the specimen type needed for testing
Specimen Required Defines the optimal specimen. This field describes the type of specimen required to perform the test and the preferred volume to complete testing. The volume allows automated processing, fastest throughput and, when indicated, repeat or reflex testing.
Specimen should arrive within 24 hours of collection.
Container/Tube: Culture transport swab (non-charcoal)
Specimen Volume: Secretions
1. Before collecting specimen, wipe away any excessive amount of secretion and discharge.
2. Obtain secretions from the mucosal membrane of the vaginal vault with a sterile swab.
3. If smear and culture are requested or both a bacterial culture and fungal culture are requested, collect a second swab to maximize test sensitivity.
Additional Information: Specimen source is required.
Forms: If not ordering electronically, submit a Microbiology Request Form (Supply T244) with the specimen.
Specimen Minimum Volume Defines the amount of specimen required to perform an assay once, including instrument and container dead space. Submitting the minimum specimen volume makes it impossible to repeat the test or perform confirmatory or perform reflex testing. In some situations, a minimum specimen volume may result in a QNS (quantity not sufficient) result, requiring a second specimen to be collected.
Viral transport media (including but not limited to M4, M5, BD viral transport media, thioglycolate broth) or specimen >7 days from collection
Specimen Stability Information Provides a description of the temperatures required to transport a specimen to the laboratory. Alternate acceptable temperature(s) are also included.
|Varies||Refrigerated (preferred)||7 days|
Clinical Information Discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory test
Candidal vulvovaginitis is believed to be the most frequent or second most frequent vaginal infection. Depending on the geographical area, its prevalence in women is estimated to be in the range of 5% to 20%. Besides Candida albicans, Candida glabrata, and Candida tropicalis are the most frequently isolated Candida species both from vulvo-vaginitis patients and from healthy carriers.
Reference Values Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.
If positive, yeast will be identified.
Meaningful diagnosis of vaginal candidiasis requires that 1) yeast are demonstrable in the affected area and 2) clinical symptoms and signs are consistent with the disease. Since in up to 20% of healthy women, yeast cells are part of the normal vaginal flora, the presence of Candida on culture may be meaningless or misleading unless other clinical factors are considered.
Clinical Reference Provides recommendations for further in-depth reading of a clinical nature
1. McCormack WM: Vulvovaginitis and cervicitis. In Principles and Practice of Infectious Diseases. 6th edition. Edited by Mandell GL, Bennett JE, and Dolin R. Philadelphia, Elsevier Inc, 2005, pp1357-1372
2. Sutton DA: Specimen Collection, Transport, and Processing: Mycology. In Manual of Clinical Microbiology. 9th edition. Edited by PR Murray, EJ Baron, et al. Washington DC. ASM Press. 2007, pp 1728-1736
Method Description Describes how the test is performed and provides a method-specific reference
Specimens are plated on inhibitory mold agar that contains chloramphenicol to inhibit bacterial contamination. Cultures are incubated at 30 degrees C for 7 days. Identification of Candida species is accomplished by a variety of physiologic, biochemical, or molecular tests. (Sutton DA: Specimen Collection, Transport, and Processing: Mycology. In Manual of Clinical Microbiology. 9th edition. Edited by PR Murray, EJ Baron, et al. Washington DC. ASM Press. 2007, pp 1728-1736)
Day(s) and Time(s) Test Performed Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.
Monday through Sunday; Varies
Analytic Time Defines the amount of time it takes the laboratory to setup and perform the test. This is defined in number of days. The shortest interval of time expressed is "same day/1 day," which means the results may be available the same day that the sample is received in the testing laboratory. One day means results are available 1 day after the sample is received in the laboratory.
7 days/Positive cultures reported when detected. Negative 7 days
Maximum Laboratory Time Defines the maximum time from specimen receipt at Mayo Medical Laboratories until the release of the test result
Specimen Retention Time Outlines the length of time after testing that a specimen is kept in the laboratory before it is discarded
Raw specimen discarded after 2 days.
Performing Laboratory Location The location of the laboratory that performs the test
Test Classification Provides information regarding the medical device classification for laboratory test kits and reagents. Tests may be classified as cleared or approved by the US Food and Drug Administration (FDA) and used per manufacturer's instructions, or as products that do not undergo full FDA review and approval, and are then labeled as an Analyte Specific Reagent (ASR), Investigation Use Only (IUO) product, or a Research Use Only (RUO) product.
This test uses a standard method. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements.
CPT Code Information Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each test or profile. The listed CPT codes reflect Mayo Medical Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.
87102-Fungal culture, vaginal
87106-Yeast identification panel C (if appropriate)
87106-Id MALDI-TOF Mass Spec Yeast (if appropriate)
87107-Fungal identification panel A (if appropriate)
87107-Fungal identification panel B (if appropriate)
87107-Yeast identification panel A (if appropriate)
87107-Yeast identification panel B (if appropriate)
87150-Identification rapid PCR Coccidioides (if appropriate)
87150 x 2-Identification Histoplasma/Blastomyces, PCR (if appropriate)
87150-Microbial probe, fungus identification (if appropriate)
87153-D2 fungal sequencing identification (if appropriate)
LOINC® Code Information Provides guidance in determining the Logical Observation Identifiers Names and Codes (LOINC) values for the result codes returned for this test or profile.
|Result ID||Reporting Name||LOINC Code|
|FVAG||Fungal Culture, Vaginal||In Process|